ABEONA THERAPEUTICS INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ABEONA THERAPEUTICS INC. (ABEO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 13.69 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- ABEONA THERAPEUTICS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 13.69M shares, a 665.47% increase year-over-year.
- ABEONA THERAPEUTICS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 14.02M shares, a 12.53% decline year-over-year.
- ABEONA THERAPEUTICS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 13.79M shares, a 1.81% decline year-over-year.
- ABEONA THERAPEUTICS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 1.79M shares, a 0.00% change year-over-year.
- ABEONA THERAPEUTICS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 1.80M shares, a 87.20% decline from fiscal 2024.
- ABEONA THERAPEUTICS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 14.10M shares, a 17.25% increase from fiscal 2023.
- ABEONA THERAPEUTICS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 12.03M shares, a 15.01% increase from fiscal 2022.
- ABEONA THERAPEUTICS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 10.46M shares, a 374.68% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 13.69M shares 10-Q · filed 2026-08-13 | 13.69M shares 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | 14.02M shares 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | 1.80M shares 10-K · filed 2026-03-17 | |||||||
| 2025-09-30 | 13.79M shares 10-Q · filed 2025-11-12 | 1.80M shares 10-Q · filed 2025-11-12 | ||||||
| 2025-06-30 | 1.79M shares 10-Q · filed 2026-08-13 | 1.79M shares 10-Q · filed 2026-08-13 | ||||||
| 2025-03-31 | 16.03M shares 10-Q · filed 2026-05-13 | |||||||
| 2024-12-31 | 14.10M shares 10-K · filed 2026-03-17 | |||||||
| 2024-09-30 | 14.05M shares 10-Q · filed 2025-11-12 | 14.05M shares 10-Q · filed 2025-11-12 | ||||||
| 2024-06-30 | 1.79M shares 10-Q · filed 2025-08-14 | 12.43M shares 10-Q · filed 2025-08-14 | ||||||
| 2024-03-31 | 12.62M shares 10-Q · filed 2025-05-15 | |||||||
| 2023-12-31 | 12.03M shares 10-K · filed 2025-03-20 | |||||||
| 2023-09-30 | 11.93M shares 10-Q · filed 2024-11-14 | 11.93M shares 10-Q · filed 2024-11-14 | ||||||
| 2023-06-30 | 12.19M shares 10-Q · filed 2024-08-12 | 12.19M shares 10-Q · filed 2024-08-12 | ||||||
| 2023-03-31 | 10.56M shares 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | 10.46M shares 10-K · filed 2024-03-18 | |||||||
| 2022-09-30 | 2.85M shares 10-Q · filed 2023-11-13 | 2.85M shares 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | 2.11M shares 10-Q · filed 2023-08-08 | |||||||
| 2022-03-31 | 2.15M shares 10-Q · filed 2023-05-11 | 53.75M shares 10-Q · filed 2022-05-13 | ||||||
| 2021-12-31 | 2.20M shares 10-K · filed 2023-03-29 | 55.07M shares 10-K · filed 2022-03-31 | ||||||
| 2021-09-30 | 424.42K shares 10-Q · filed 2022-11-14 | 10.74M shares 10-Q · filed 2021-11-15 | 424.42K shares 10-Q · filed 2022-11-14 | 10.74M shares 10-Q · filed 2021-11-15 | ||||
| 2021-06-30 | 11.05M shares 10-Q · filed 2021-07-28 | 437.78K shares 10-Q · filed 2022-08-11 | 11.05M shares 10-Q · filed 2021-07-28 | |||||
| 2021-03-31 | 9.80M shares 10-Q · filed 2022-05-13 | 9.73M shares 10-Q · filed 2021-05-17 | ||||||
| 2020-12-31 | 8.64M shares 10-K · filed 2022-03-31 | |||||||
| 2020-09-30 | 7.25M shares 10-Q · filed 2021-11-15 | 6.43M shares 10-Q · filed 2020-11-09 | 7.25M shares 10-Q · filed 2021-11-15 | 6.43M shares 10-Q · filed 2020-11-09 | ||||
| 2020-06-30 | 8.89M shares 10-Q · filed 2021-07-28 | 7.81M shares 10-Q · filed 2020-08-10 | 8.89M shares 10-Q · filed 2021-07-28 | 7.81M shares 10-Q · filed 2020-08-10 | ||||
| 2020-03-31 | 6.76M shares 10-Q · filed 2021-05-17 | |||||||
| 2019-12-31 | 6.48M shares 10-K · filed 2021-03-24 | 6.13M shares 10-K · filed 2020-03-16 | ||||||
| 2019-09-30 | 8.52M shares 10-Q · filed 2020-11-09 | 8.52M shares 10-Q · filed 2020-11-09 | ||||||
| 2019-06-30 | 8.75M shares 10-Q · filed 2020-08-10 | 8.75M shares 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | 7.52M shares 10-Q · filed 2020-05-06 | |||||||
| 2018-12-31 | 7.66M shares 10-K · filed 2020-03-16 | |||||||
| 2017-12-31 | 8.36M shares 10-K · filed 2020-03-16 | |||||||
| 2016-12-31 | 8.51M shares 10-K · filed 2019-03-18 | |||||||
| 2015-12-31 | 6.12M shares 10-K · filed 2017-03-30 | |||||||
| 2014-12-31 | 4.37M shares 10-K · filed 2016-03-30 | |||||||
| 2014-09-30 | 2.53M shares 10-Q · filed 2014-11-14 | 2.53M shares 10-Q · filed 2014-11-14 | ||||||
| 2014-06-30 | 118.69M shares 10-Q · filed 2014-08-14 | 118.69M shares 10-Q · filed 2014-08-14 | ||||||
| 2014-03-31 | 121.08M shares 10-Q · filed 2014-05-12 | |||||||
| 2013-12-31 | 2.22M shares 10-K · filed 2015-03-31 | 110.87M shares 10-K · filed 2014-03-26 | ||||||
| 2013-09-30 | 2.33M shares 10-Q · filed 2014-11-14 | 116.22M shares 10-Q · filed 2013-11-14 | 2.32M shares 10-Q · filed 2014-11-14 | 115.67M shares 10-Q · filed 2013-11-14 | ||||
| 2013-06-30 | 115.92M shares 10-Q · filed 2014-08-14 | 115.92M shares 10-Q · filed 2014-08-14 | ||||||
| 2013-03-31 | 114.82M shares 10-Q · filed 2014-05-12 | |||||||
| 2012-12-31 | 116.70M shares 10-K · filed 2014-03-26 | |||||||
| 2012-09-30 | 38.67M shares 10-Q · filed 2013-11-14 | 38.67M shares 10-Q · filed 2013-11-14 | ||||||
| 2012-06-30 | 38.86M shares 10-Q · filed 2013-08-14 | 38.86M shares 10-Q · filed 2013-08-14 | ||||||
| 2011-12-31 | 38.85M shares 10-K · filed 2013-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |